Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo

Mol Hum Reprod. 2010 Oct;16(10):761-9. doi: 10.1093/molehr/gaq049. Epub 2010 Jun 14.

Abstract

The aim of this study is the identification of direct endothelial regulation by the androgens testosterone (T) and dihydrotestosterone (DHT). We tested the effects of T and DHT on nitric oxide (NO) synthesis and on tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) expression in human endothelial cells and in ovariectomized (OVX) rats. The results showed that at physiological concentrations T and DHT increase endothelial synthesis of NO. This depends on a rapid recruitment of the extracellular-related kinase (ERK) 1/2 and of the phosphatidylinositol 3-OH kinase (PI3K)/Akt cascades, resulting in endothelial nitric oxide synthase (eNOS) Ser(1177)-phosphorylation. In addition, a later increase of eNOS expression is found. With supra-physiological amounts of T or DHT the induction of NO synthesis is lost. A concentration-related increase of t-PA expression starting from physiological concentrations of T or DHT is found, whereas PAI-1 is augmented only with higher doses. Although DHT exerts these actions through androgen receptors (AR), T acts in part through aromatase-dependent conversion to 17β-estradiol. Ovariectomy is associated with significant changes in eNOS, t-PA and PAI-1 expression in the aorta of Wistar rats and T and DHT result in modifications on eNOS, PAI-1 and t-PA that are in line with the in vitro experiments. In conclusion, T and DHT act on endothelial cells through AR or via conversion to estradiol. Physiological, but not higher amounts are associated with enhanced NO synthesis and an increased t-PA/PAI-1 ratio. These findings are useful to understand the impact of androgens in ageing individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Dihydrotestosterone / pharmacology*
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism*
  • Female
  • Humans
  • Immunoblotting
  • Male
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism*
  • Plasminogen Activator Inhibitor 1 / metabolism*
  • Rats
  • Rats, Wistar
  • Testosterone / pharmacology*
  • Tissue Plasminogen Activator / metabolism*

Substances

  • Plasminogen Activator Inhibitor 1
  • Dihydrotestosterone
  • Nitric Oxide
  • Testosterone
  • Nitric Oxide Synthase Type III
  • Tissue Plasminogen Activator